.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Kerala government recently approved the Kerala Universal Health Coverage scheme to provide medical protection for every citizen. Health Minister Veena George confirmed this significant development following extensive discussions and review meetings. This initiative aims to include families currently excluded from programs like Karunya Arogya Suraksha Padhathi (KASP) and MEDISEP. Consequently, lakhs of families will now receive essential treatment assistance through this comprehensive project.
Historically, the government limited treatment assistance to a small number of families. However, the state has significantly expanded these benefits over the last decade. Currently, the KASP scheme provides coverage of up to Rs 5 lakh per year to approximately 42 lakh families. Despite this progress, many households still lacked adequate insurance. Therefore, the new project specifically targets those who fall through the cracks of existing frameworks. This expansion reflects the state's commitment to the Vision 2031 goals for public health.
Families with an annual income below Rs 3 lakh can access up to Rs 2 lakh for treatment. Furthermore, they receive an additional Rs 1 lakh benefit for kidney-related diseases under the Karunya Benevolent Fund. The Health Department prepared this proposal in 2025 after a detailed analysis of the state's healthcare needs. Chief Minister Pinarayi Vijayan chaired meetings in November to finalize the project's roadmap. Ultimately, the state budget officially announced the scheme to ensure long-term sustainability.
Q1: Who is eligible for the new Kerala Universal Health Coverage scheme?
The scheme targets families who are not currently covered by existing programs like KASP, MEDISEP, or the Karunya Benevolent Fund, especially those with an annual income below Rs 3 lakh.
Q2: What is the maximum coverage amount under the new project?
Eligible families can receive treatment assistance of up to Rs 2 lakh, with additional benefits of up to Rs 1 lakh specifically for kidney-related ailments.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Kerala Health Minister Veena George approves the Universal Health Coverage scheme to provide medical protection to families excluded from existing programs....
4 months ago
Early cancer detection offers the highest promise for oncological cures, yet every screening modality involves a critical balance between diagnostic benefit and potential harm. From low-dose CT for heavy smokers to emerging blood-based multi-cancer early detection (MCED) tests, understanding trade-offs is essential.
Today
A recent analysis in The Lancet Regional Health Southeast Asia reveals that Uttar Pradesh and Bihar accounted for nearly half of India's stillbirths in 2023. The study highlights significant undercounting due to definition thresholds, underscoring the need for earlier surveillance and enhanced maternal care.
Today
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
5 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
5 days back
The Delhi High Court has issued a notice to the Centre and FSSAI regarding a plea for an India-specific scientific evaluation of non-sugar sweeteners. The petition highlights concerns over metabolic risks, front-of-pack labeling, and misleading health claims on artificial substitutes.
Today
